Company Overview
- Website
- eurofinsus.com/biodiagnostics
- Phone
- (715) 426-0246
- Employees
- 55
- Founded in
- 1996
- Industry
- BioTech/Drugs
- NAICS Codes
-
54 - Professional, Scientific, and Technical Services541 - Professional, Scientific, and Technical Services62 - Health Care and Social Assistance621 - Ambulatory Health Care Services
- SIC Codes
-
80 - Health Services807 - Medical and Dental Laboratories87 - Engineering, Accounting, Research, Management, and Related Services873 - Research, Development, and Testing Services
Financials & Stats
Revenue
$24B
Recent News & Media
MRI Radiomic Features: A Potential Biomarker for Progression-Free Survival Prediction of Patients With Locally Advanced Cervical Cancer Undergoing Surgery
- Dec 5, 2024
- pmc.ncbi.nlm.nih.gov
Comparative analysis of clinicopathological characteristics of central necrotizing breast cancer and basal cell-like breast cancer
- Nov 29, 2024
- pmc.ncbi.nlm.nih.gov
Nanostics and Protean BioDiagnostics Partner to Launch CDX Prostate for Men at Risk of Having Aggressive Prostate Cancer in the United States
- Sep 24, 2024
- businesswire.com
Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers
- Oct 4, 2023
- businesswire.com
ChromaCode and Protean BioDiagnostics Establish Strategic Partnership to Introduce a HDPCR-based NSCLC Assay in the U.S.
- Aug 10, 2023
- biospace.com
Eurofins BioDiagnostics adds BDI Prime Seq to Accelerate Corn Breeding Efforts
- Dec 9, 2021
- seedworld.com